Hexagon Nutrition Ltd. IPO
IPO Timeline
-
5 Jun 2026Bidding Starts
-
9 Jun 2026Bidding Ends
-
10 Jun 2026Allotment Finalization
-
12 Jun 2026Listing
About Hexagon Nutrition Ltd.
We are a differentiated and research-oriented pure play nutrition Company. We are holistic nutrition player that offers products across a whole range starting with micronutrient premixes, right up to therapeutic and clinical products (Source: CARE Report). We are also one of the largest premix players in India, offering customised vitamin and mineral premixes to leading Indian and multinational FMCG companies. It is also one of the largest licensed suppliers of Micronutrient Powders (MNPs) under UN programmes, supporting global food fortification and public health initiatives (Source: CARE Report). Our product portfolio addresses a broad spectrum of nutritional aspects such as fortification of foods, therapeutic nutrition, clinical nutrition and alleviation of malnutrition. We are a fully integrated company engaged across the entire value chain, right from research and product development to manufacturing and marketing, with a focus on quality.
Our Company began our journey in the year 1993 as a micronutrient formulations player and have steadily moved up the value chain to develop our brands such as “PENTASURE”, “OBESIGO” and “PEDIAGOLD” in the health, wellness, and clinical nutrition space. In Fiscal 2024, our Company further expanded our portfolio with the launch of a new brand, “NUTRONE”, strengthening our position in the segment. Our presence spans across India, and our products have been exported to over 75 countries during the nine month period ended December 31, 2025 and Fiscals 2023, 2024 and 2025.
We operate three (3) manufacturing facilities in India, located in Nasik (Maharashtra), Chennai (Tamil Nadu) and hoothukudi (Tamil Nadu), along with one (1) international manufacturing facility in Tashkent, Uzbekistan. Two of our Indian manufacturing facilities is situated in SEZ zones in Chennai (Tamil Nadu) and Thoothukudi (Tamil Nadu) and offers strategic advantages such as proximity to major ports and access to duty-free imports. For details, see “Our Business - Our Manufacturing Facilities” on page 280. Our integrated and standardized manufacturing processes enable us to maintain the quality of the products. We continuously strive to implement rigorous quality control and food safety measures across the entire production chain, from the procurement of raw materials to the finished product. Our manufacturing facilities have received various certifications and accreditations, including the FSSC 22000, Good Manufacturing Practice (GMP) certification, ISO 9001:2015 Certification, Halal Certification, amongst others from various local and international accreditation agencies. For details of quality certification obtained by each of our Facility. These certifications validate our commitment to quality, safety, and regulatory compliance across global markets.
Hexagon Nutrition Ltd. IPO Reservation
| Investors Category | Shares Offered |
|---|---|
| Anchor Investors | 92,57,911 (30%) |
| Non Institutional Investors | 46,28,956 (15%) |
| Qualified Institutional Buyers (QIBs) | 61,71,941 (20%) |
| Retail Individual Investors (RIIs) | 1,08,00,896 (35%) |
Hexagon Nutrition Ltd. Financial Information
| Year End | Revenue | PAT | Reserves & Surplus |
|---|---|---|---|
| 31 Mar 2025 | 163.92 Cr | 11.57 Cr | 55.77 Cr |
| 31 Mar 2024 | 137.80 Cr | 10.46 Cr | 49.27 Cr |
| 31 Mar 2023 | 120.04 Cr | 55.00 Lakh | 38.64 Cr |
Hexagon Nutrition Ltd. Background
-
1993Incorporation of our Company as ‘Hexagon Chemoils Private Limited’, a private limited company under the Companies Act, 1956 at Mumbai, Maharashtra
-
2001Commence manufacturing operations at Plot No. 92 of our Nashik Facility
-
2004Started second manufacturing unit in Chennai SEZ (MEPZ) to facilitate imports and increase exports.
-
2009Launched our flagship brand “Pentasure”
-
2012Incorporated a wholly owned subsidiary in Thoothukudi
-
2013Received in principle approval for grant in aid from Indian Council of Agriculture Research (ICAR) for setup of food testing laboratory.
-
2016Investment by Somerset Indus Healthcare Fund I Limited in our Company.
Merger amongst Hexagon Logistics Private Limited, Hexagon Vitachemie Private Limited, Nivia Biotech Private Limited (collectively referred to as “Transferor Companies”) and Hexagon Nutrition Private Limited (“Transferee Company”) and their respective shareholders and creditors.
Our Branded Segment crossed ₹1,000 million mark
-
2017Received DSIR approval from Government of India for R&D Facility at Chennai
-
2018Received approval of UNICEF for production of Micro Nutrient Powder (MNP)
-
2020Incorporated a wholly owned subsidiary in Uzbekistan i.e. Hexagon Nutrition Limited Liability Company and Hong Kong China i.e. Hexagon Nutrition China Limited
We acquired a company in South Africa i.e. Hexagon Nutrition Proprietary Limited (South Africa), and pursuant to such acquisition, it has been constituted as our wholly owned subsidiary.
-
2021Converted from Private Limited to Public Limited Company.
-
2022Amalgamation of Nutralytica Research Private Limited and Hexagon Nutrition Limited
-
2023Launch of our new brand “Nutrone”
-
2024Certificate of recognition in favour of our Company for being part in Dun and Bradstreet Global Database
-
2025Crossed an annual turnover of ₹3,000 million
Exit of Private Equity Investors, Somerset Indus Healthcare Fund I Limited and Mayur Sirdesai
-
2026Our Branded Segment crossed ₹1,000 million mark
Our Wholly Owned Subsidiary, Hexagon Nutrition (Exports) Private Limited (HNEPL) was amalgamated with the Company, Hexagon Nutrition Limited pursuant to the order dated January 14, 2026, passed by the Hon’ble National Company Law Tribunal (NCLT), with appointed dated being April 1, 2025
1. Carry out the Offer for Sale of up to 30,859,704 Equity Shares bearing face value of ?1 each by the Selling Shareholders aggregating up to ? [?] million
2. Achieve the benefits of listing the Equity Shares on the Stock Exchanges
| Pricing Details | BSE | NSE |
|---|---|---|
| Issue Price | ₹ 45.00 | ₹ 45.00 |
| Open | ₹ 48.00 | ₹ 48.25 |
| Low | ₹ 48.00 | ₹ 48.10 |
| High | ₹ 50.39 | ₹ 50.66 |
| Last Trade | ₹ 50.39 | ₹ 50.66 |
1. Arun Purushottam Kelkar
2. Subhash Purushottam Kelkar
3. Vikram Arun Kelkar
4. Nikhil Arun Kelkar
5. Aditya Kelkar
The global nutrition market shows distinct regional trends shaped by cultural preferences, demographics, and income levels. In the United States, personalised nutrition is gaining traction as consumers embrace apps and wearables to tailor their dietary choices. Germany maintains a strong focus on ... Read more
FAQs
When does Hexagon Nutrition Ltd. IPO opens and closes?
Hexagon Nutrition Ltd. IPO opens from 5th June to 9th June 2026.What is the size of Hexagon Nutrition Ltd. IPO?
The size of the Hexagon Nutrition Ltd. IPO is ₹138.87 Cr.What is the price range of Hexagon Nutrition Ltd. IPO?
The price range of Hexagon Nutrition Ltd. IPO is at ₹42 to ₹45 per share.What is the minimum investment and lot size required for the Hexagon Nutrition Ltd. IPO?
The minimum investment required is ₹14,985 and minimum lot size is 333 shares.When is Hexagon Nutrition Ltd. IPO listing date?
The Hexagon Nutrition Ltd. IPO will be listed on 12th June 2026.What is the objective of Hexagon Nutrition Ltd. IPO?
1. Carry out the Offer for Sale of up to 30,859,704 Equity Shares bearing face value of ?1 each by the Selling Shareholders aggregating up to ? [?] million2. Achieve the benefits of listing the Equity Shares on the Stock Exchanges
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article


Click it and Unblock the Notifications